This is, in particular, a problem for triple-negative BC (TNBC), a particularly aggressive form of BC, where the cancer cells lack receptors for estrogen, progesterone, and HER2, which limits the treatment options compared to other breast cancer types [5]. Here, ERBB2 is linked to breast cancer.